MLICM
VERA icon

Metropolitan Life Insurance Company (MetLife)’s Vera Therapeutics VERA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,125
Closed -$91.6K – 2035
2024
Q1 		$91.6K Sell
2,125
-147
-6% -$5.24K ﹤0.01% 1092
2023
Q4 		$34.9K Hold
2,272
– – ﹤0.01% 1632
2023
Q3 		$31.1K Buy
2,272
+384
+20% +$6.59K ﹤0.01% 1660
2023
Q2 		$30.3K Buy
1,888
+560
+42% +$5.06K ﹤0.01% 1708
2023
Q1 		$10.3K Buy
1,328
+287
+28% +$2.21K ﹤0.01% 2150
2022
Q4 		$20.1K Hold
1,041
– – ﹤0.01% 2007
2022
Q3 		$22.2K Hold
1,041
– – ﹤0.01% 1975
2022
Q2 		$14.2K Hold
1,041
– – ﹤0.01% 2211
2022
Q1 		$24.5K Buy
+1,041
New +$22.4K ﹤0.01% 1999

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VERA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Vera Therapeutics (VERA) in Q2 2024, closing a stake of 2,125 shares — an estimated $91.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VERA in Q1 2022 and held it in 9 quarters. The position peaked at $91.6K in Q1 2024. 171 funds tracked by Wall St. Rank hold VERA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Vera Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,125 Vera Therapeutics shares in Q2 2024, an estimated $91.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Vera Therapeutics in Q1 2022 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Vera Therapeutics position peaked at $91.6K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.